GoodRx Holdings (GDRX) Change in Account Payables (2019 - 2026)

GoodRx Holdings has disclosed Change in Account Payables across 8 years of filings, most recently posting -$4.9 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at -$4.9 million, down 1829.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 91.38% YoY), and the FY2025 annual result was $4.1 million, up 125.94% from the prior year.
• Change in Account Payables came in at -$4.9 million for Q1 2026 at GoodRx Holdings, up from -$10.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $25.5 million in Q3 2023 to a low of -$15.6 million in Q2 2024.
• The 5-year median for Change in Account Payables is -$2.5 million (2023), against an average of -$323588.2.
• Across the five-year window, Change in Account Payables surged 10030.77% in 2022 and sank 1829.02% in 2026, its largest moves.
• GoodRx Holdings' Change in Account Payables stood at $7.1 million in 2022, then sank by 134.76% to -$2.5 million in 2023, then soared by 396.17% to $7.3 million in 2024, then tumbled by 243.2% to -$10.5 million in 2025, then surged by 53.0% to -$4.9 million in 2026.
• The last three Change in Account Payables figures came in at -$4.9 million (Q1 2026), -$10.5 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.